Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT (Unaudited)

v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-In Capital [Member]
Loan Receivable From EJ Holdings [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Deficit [Member]
Balance, beginning at Dec. 31, 2022 $ (34,091) $ 50 $ 220,815   $ (2,619) $ (252,337)
Balance, beginning (in shares) at Dec. 31, 2022   49,583,501        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Fair value of warrants including down-round protection adjustments     41     (41)
Convertible notes converted to shares (in shares)   1,351,351        
Convertible notes converted to shares 500 $ 1 499      
Share-based compensation 38   38      
Unrealized loss on debt securities available for sale (net of tax) (544)       (544)  
Foreign currency translation effect 186       186  
Net loss (3,451)         (3,451)
Balance, ending at Mar. 31, 2023 (37,362) $ 51 221,393   (2,977) (255,829)
Balance, ending (in shares) at Mar. 31, 2023   50,934,852        
Balance, beginning at Dec. 31, 2023 (47,756) $ 62 225,333 $ (16,869) (160) (256,122)
Balance, beginning (in shares) at Dec. 31, 2023   61,845,963        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation 170   170      
Unrealized loss on debt securities available for sale (net of tax) (1,728)       (1,728)  
Foreign currency translation effect 18       18  
Net loss (4,348)         (4,348)
Balance, ending at Mar. 31, 2024 $ (53,644) $ 62 $ 225,503 $ (16,869) $ (1,870) $ (260,470)
Balance, ending (in shares) at Mar. 31, 2024   61,845,963